Cancer Drugs Aim at More Targets

Cancer Drugs Aim at More Targets

Good article from Wired on the new cancer drugs coming to market soon. “These drugs represent the next generation of anti-angiogenesis drugs beyond Avastin,” said William Li, president and medical director of the Angiogenesis Foundation, a non-profit institution based in Cambridge, Massachusetts. “If chemotherapy is like a dirty bomb and Avastin like a smart bomb, then the new therapies are more like cluster bombs that have multiple targets.”

Leave a Reply

Your email address will not be published. Required fields are marked *

*